Try it
Biochemistry · Biomolecules and enzymes: heparin and antithrombin
Sample itemA patient on unfractionated heparin has a prolonged aPTT. The drug acts by binding, through a specific sulfated pentasaccharide sequence, to which plasma protein and enhancing its inhibition of clotting factors?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. Antithrombin
Heparin is a highly sulfated glycosaminoglycan with the greatest negative charge density of any biological macromolecule. Its pentasaccharide sequence binds antithrombin and causes a conformational change that speeds inactivation of thrombin and factor Xa by about a thousand-fold.
Option by option
A. Plasminogen
Plasminogen is the precursor of plasmin in fibrinolysis; heparin does not bind it to produce anticoagulation.
B. Antithrombin (correct)
Correct. The heparin pentasaccharide activates antithrombin, which then inhibits thrombin and factor Xa.
C. Alpha-2 antiplasmin
Alpha-2 antiplasmin inhibits plasmin, so enhancing it would reduce fibrinolysis rather than clotting.
D. Protein C
Protein C is a vitamin K-dependent anticoagulant activated by thrombin-thrombomodulin, and heparin does not act through it.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Biochemistry questions
- Nucleotide metabolismA 4-year-old boy has intellectual disability, dystonia, self-mutilation and hyperuricaem…
- VitaminsA patient with megaloblastic anaemia and mild neurological signs has raised serum methyl…
- Amino acid metabolismA baby has a mousy odour, fair skin and developmental delay. Which enzyme is deficient?
- Glycogen storage diseasesA child has severe fasting hypoglycaemia, hepatomegaly, lactic acidosis and hyperuricaem…